European Pharmaceuticals
Alternatives
Geoffrey C. Hsu, partner of OrbiMed and manager of the BiotechGrowth trust, assesses the key drivers for the sector in 2016 and beyond.
08 November 2015
•
4 min read
Investment
The era of 'Big Pharma' is over and companies are transitioning to more complex biological products, explains Tim Crockford from Hermes Sourcecap.
11 June 2014
•
Most read
01
Somerset Capital loses two-thirds of assets as SJP severs ties - reports
04 December 2023
•
1 min read
02
Premier Miton takes 60% profit hit as net outflows climb to £1.1bn
05 December 2023
•
2 min read
03
On the night gallery: Women in Investment Awards 2023
04 December 2023
•
1 min read
04
St James's Place reshuffles managers and alters charges on fund trio
04 December 2023
•
2 min read
05
Rent collection dwindles to 14% as further Home REIT tenant enters liquidation
05 December 2023
•
2 min read
